These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 14692776)

  • 1. A superoxo-ferrous state in a reduced oxy-ferrous hemoprotein and model compounds.
    Davydov R; Satterlee JD; Fujii H; Sauer-Masarwa A; Busch DH; Hoffman BM
    J Am Chem Soc; 2003 Dec; 125(52):16340-6. PubMed ID: 14692776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EPR and ENDOR characterization of the reactive intermediates in the generation of NO by cryoreduced oxy-nitric oxide synthase from Geobacillus stearothermophilus.
    Davydov R; Sudhamsu J; Lees NS; Crane BR; Hoffman BM
    J Am Chem Soc; 2009 Oct; 131(40):14493-507. PubMed ID: 19754116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EPR and ENDOR studies of cryoreduced compounds II of peroxidases and myoglobin. Proton-coupled electron transfer and protonation status of ferryl hemes.
    Davydov R; Osborne RL; Kim SH; Dawson JH; Hoffman BM
    Biochemistry; 2008 May; 47(18):5147-55. PubMed ID: 18407661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformational substates of the oxyheme centers in alpha and beta subunits of hemoglobin as disclosed by EPR and ENDOR studies of cryoreduced protein.
    Davydov R; Kofman V; Nocek JM; Noble RW; Hui H; Hoffman BM
    Biochemistry; 2004 May; 43(20):6330-8. PubMed ID: 15147217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient species involved in catalytic dioxygen/peroxide activation by hemoproteins: possible involvement of protonated Compound I species.
    Silaghi-Dumitrescu R; Cooper CE
    Dalton Trans; 2005 Nov; (21):3477-82. PubMed ID: 16234928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence That Compound I Is the Active Species in Both the Hydroxylase and Lyase Steps by Which P450scc Converts Cholesterol to Pregnenolone: EPR/ENDOR/Cryoreduction/Annealing Studies.
    Davydov R; Strushkevich N; Smil D; Yantsevich A; Gilep A; Usanov S; Hoffman BM
    Biochemistry; 2015 Dec; 54(48):7089-97. PubMed ID: 26603348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate modulation of the properties and reactivity of the oxy-ferrous and hydroperoxo-ferric intermediates of cytochrome P450cam as shown by cryoreduction-EPR/ENDOR spectroscopy.
    Davydov R; Perera R; Jin S; Yang TC; Bryson TA; Sono M; Dawson JH; Hoffman BM
    J Am Chem Soc; 2005 Feb; 127(5):1403-13. PubMed ID: 15686372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of substrate on the diiron(III) site in stearoyl acyl carrier protein delta 9-desaturase as disclosed by cryoreduction electron paramagnetic resonance/electron nuclear double resonance spectroscopy.
    Davydov R; Behrouzian B; Smoukov S; Stubbe J; Hoffman BM; Shanklin J
    Biochemistry; 2005 Feb; 44(4):1309-15. PubMed ID: 15667224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound I is the reactive intermediate in the first monooxygenation step during conversion of cholesterol to pregnenolone by cytochrome P450scc: EPR/ENDOR/cryoreduction/annealing studies.
    Davydov R; Gilep AA; Strushkevich NV; Usanov SA; Hoffman BM
    J Am Chem Soc; 2012 Oct; 134(41):17149-56. PubMed ID: 23039857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The coordination of imidazole and substituted pyridines by the hemeoctapeptide N-acetyl-ferromicroperoxidase-8 (FeIINAcMP8).
    Vashi PR; Marques HM
    J Inorg Biochem; 2004 Sep; 98(9):1471-82. PubMed ID: 15337599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on an iron(iii)-peroxo porphyrin. Iron(III)-peroxo or iron(II)-superoxo?
    Duerr K; Olah J; Davydov R; Kleimann M; Li J; Lang N; Puchta R; Hübner E; Drewello T; Harvey JN; Jux N; Ivanović-Burmazović I
    Dalton Trans; 2010 Feb; 39(8):2049-56. PubMed ID: 20148224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the role of the N-terminal proline, the distal heme ligand in the CO sensor CooA.
    Clark RW; Youn H; Parks RB; Cherney MM; Roberts GP; Burstyn JN
    Biochemistry; 2004 Nov; 43(44):14149-60. PubMed ID: 15518565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heme ferrous-hydroperoxo complexes: some theoretical considerations.
    Silaghi-Dumitrescu R
    Arch Biochem Biophys; 2004 Apr; 424(2):137-40. PubMed ID: 15047185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of an end-on ferric peroxo intermediate upon one-electron reduction of a ferric superoxo heme.
    Liu JG; Shimizu Y; Ohta T; Naruta Y
    J Am Chem Soc; 2010 Mar; 132(11):3672-3. PubMed ID: 20196593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electron paramagnetic resonance and electron-nuclear double resonance studies of the reactions of cryogenerated hydroperoxoferric-hemoprotein intermediates.
    Davydov R; Laryukhin M; Ledbetter-Rogers A; Sono M; Dawson JH; Hoffman BM
    Biochemistry; 2014 Aug; 53(30):4894-903. PubMed ID: 25046203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heme/Cu/O2 reactivity: change in FeIII-(O2 2-)-CuII unit peroxo binding geometry effected by tridentate copper chelation.
    Kim E; Shearer J; Lu S; Moënne-Loccoz P; Helton ME; Kaderli S; Zuberbühler AD; Karlin KD
    J Am Chem Soc; 2004 Oct; 126(40):12716-7. PubMed ID: 15469233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of electronic structure and properties of a Bis(histidine) heme model complex.
    Smith DM; Dupuis M; Vorpagel ER; Straatsma TP
    J Am Chem Soc; 2003 Mar; 125(9):2711-7. PubMed ID: 12603159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryoreduction EPR and 13C, 19F ENDOR study of substrate-bound substates and solvent kinetic isotope effects in the catalytic cycle of cytochrome P450cam and its T252A mutant.
    Kim SH; Yang TC; Perera R; Jin S; Bryson TA; Sono M; Davydov R; Dawson JH; Hoffman BM
    Dalton Trans; 2005 Nov; (21):3464-9. PubMed ID: 16234926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electronic structure of six-coordinate iron(III)-porphyrin NO adducts: the elusive iron(III)-NO(radical) state and its influence on the properties of these complexes.
    Praneeth VK; Paulat F; Berto TC; George SD; Näther C; Sulok CD; Lehnert N
    J Am Chem Soc; 2008 Nov; 130(46):15288-303. PubMed ID: 18942830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volume profile analysis for the reversible binding of superoxide to form iron(II)-superoxo/Iron(III)-peroxo porphyrin complexes.
    Dürr K; Jux N; Zahl A; van Eldik R; Ivanović-Burmazović I
    Inorg Chem; 2010 Dec; 49(23):11254-60. PubMed ID: 21058668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.